Sort
78,016 grants matching “breast cancer”
Identifying effective risk-based supplemental ultrasound screening strategies for women with dense breasts
$707,023Brian L Sprague · University Of Vermont & St Agric College · R01 · FY2024 · CA
Moffitt Imaging Biomarker VAlidation Center
$706,998Jae K. Lee · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2016 · CA
Clinical decision-support algorithms for interactive design of patient-specific breast molds
$706,950Fatima A Merchant · University Of Houston · R01 · FY2025 · CA
MBRS SCORE Program at UPR, Medical Sciences Campus
$706,916University Of Puerto Rico Med Sciences · S06 · FY2002 · GM
Detection of metastases in lymph nodes using quantitative ultrasound
$706,909Ernest Joseph Feleppa · Riverside Research Institute · R01 · FY2016 · CA
NORTH CENTRAL CANCER TREATMENT GROUP
$706,898Mayo Clinic Coll Of Medicine, Rochester · U10 · FY2003 · CA
SMART Cancer Care Teams: Enhancing EHR Communication to Improve Interprofessional Teamwork
$706,838Shin-Ping Tu · University Of California At Davis · R01 · FY2022 · CA
TARGETING DRIVERS OF AGGRESSIVE TRIPLE-NEGATIVE BREAST CANCER IN AFRICAN AMERICANS
$706,782Washington University, The · · FY2018 · Department of the Army
Statistical Genetics of Dose Response Traits
$706,749Alison Motsinger-Reif · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
The MB-CCOP at Boston Medical Center
$706,684Lisa A. Kachnic · Boston Medical Center · U10 · FY2010 · CA
Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors with Chronic Lymphedema
$706,669Jie Deng · University Of Pennsylvania · R01 · FY2025 · CA
Deciphering the Acidic Tumor Environment: A Phase I/IIa Study of Pre-Operative Multiparametric MRI and pHLIP® ICG Intra-Operative Fluorescence Imaging of Primary Breast Cancer
$706,536Katja Pinker-Domenig · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
RATIONAL TARGETING OF TTK/MPS1 IN HER2-NEGATIVE BREAST CANCER
$706,500Rush University Medical Center · · FY2022 · Defense Health Agency
Immunotherapy to deplete key Treg subsets in solid tumors
$706,495Peter David Suzdak · Sonoval Llc · R44 · FY2025 · CA
Stroger Hospital of Cook County, Department of Surgery,*
$706,480Thomas Lad · Hektoen Institute For Medical Research · U10 · FY2008 · CA
Placental Responses to Environmental Chemicals
$706,477Lauren M Aleksunes · Rutgers, The State Univ Of N.J. · R01 · FY2020 · ES
Consequences of chromosomal aberrations on the cancer transcriptome
$706,409Thomas Ried · Basic Sciences · Z01 · FY2007 · CA
Understanding the mechanisms of chromosomal aberrations in cancer
$706,409Thomas Ried · Basic Sciences · Z01 · FY2007 · CA
Identification of genomic markers for disease progression in cervical, breast an
$706,409Thomas Ried · Basic Sciences · Z01 · FY2007 · CA
Project 3: Integration of mammographic AI, clinical, and genomics information to improve breast cancer subtype-specific risk-based screening and prevention
$706,347Vignesh A Arasu · University Of California, San Francisco · P01 · FY2024 · CA
Alleviation of chemotherapy-induced cardiovascular toxicity
$706,230Yanbo Fan · Ohio State University · R01 · FY2025 · HL
Core 1
$706,228Ann G Schwartz · Wayne State University · P01 · FY2024 · CA
Understanding and addressing rejection of personalized cancer risk information
$706,184Laura D. Scherer · University Of Colorado Denver · R01 · FY2024 · CA
Development of TGF-beta antagonists for cancer therapy
$706,168Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
$706,093Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI